Trial NCT03207542

View at ClinicalTrials.gov 
Org. Study IDs: 2016-0973
Secondary IDs: NCI-2018-01131

Last trial update was posted on 2018-07-26

MeSH Interventions

Daratumumab

MeSH Conditions

Leukemia Leukemia, Lymphoid Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic

Stopping Reasons

PI request

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID